These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Cyclophosphamide and etoposide for non-small cell and small cell lung cancer. Grunberg SM Drugs; 1999; 58 Suppl 3():11-5. PubMed ID: 10711836 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis and treatment of patients with testicular germ cell cancer. Hartmann JT; Kanz L; Bokemeyer C Drugs; 1999 Aug; 58(2):257-81. PubMed ID: 10473019 [TBL] [Abstract][Full Text] [Related]
44. Long-term effects on sexual function and fertility after treatment of testicular cancer. Hartmann JT; Albrecht C; Schmoll HJ; Kuczyk MA; Kollmannsberger C; Bokemeyer C Br J Cancer; 1999 May; 80(5-6):801-7. PubMed ID: 10360658 [TBL] [Abstract][Full Text] [Related]
45. In vitro drug sensitivity testing of human testicular germ cell tumours with cytostatic drugs and interferon alpha-2b. Küpeli B; Baltaci S; Beksac M; Süzer O; Küpeli S; Göğüs O Int Urol Nephrol; 1997; 29(1):79-84. PubMed ID: 9203042 [TBL] [Abstract][Full Text] [Related]
47. Etoposide: current status and future perspectives in the management of malignant neoplasms. Belani CP; Doyle LA; Aisner J Cancer Chemother Pharmacol; 1994; 34 Suppl():S118-26. PubMed ID: 8070020 [TBL] [Abstract][Full Text] [Related]
48. Phase I study of high-dose cisplatin, ifosfamide, and etoposide. Perez EA; Sowray PC; Gardner SL; Gandara DR Cancer Chemother Pharmacol; 1994; 34(4):331-4. PubMed ID: 8033300 [TBL] [Abstract][Full Text] [Related]
49. Treatment intensification in disseminated germ-cell tumors. Beyer J; Bokemeyer C; Schmoll HJ; Siegert W World J Urol; 1994; 12(4):207-13. PubMed ID: 7820143 [TBL] [Abstract][Full Text] [Related]
50. Thymomas. Current experience and future directions in therapy. Loehrer PJ Drugs; 1993 Apr; 45(4):477-87. PubMed ID: 7684669 [No Abstract] [Full Text] [Related]
51. Prognosis after salvage treatment for unselected male patients with germ cell tumours. Gerl A; Clemm C; Schmeller N; Hartenstein R; Lamerz R; Wilmanns W Br J Cancer; 1995 Oct; 72(4):1026-32. PubMed ID: 7547217 [TBL] [Abstract][Full Text] [Related]
52. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer. Henwood JM; Brogden RN Drugs; 1990 Mar; 39(3):438-90. PubMed ID: 2184009 [No Abstract] [Full Text] [Related]
53. Dosing and side-effects of ifosfamide plus mesna. Brade WP; Herdrich K; Kachel-Fischer U; Araujo CE J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S164-86. PubMed ID: 1795007 [TBL] [Abstract][Full Text] [Related]
54. Optimal drug therapy in the treatment of testicular cancer. Priest ER; Vogelzang NJ Drugs; 1991 Jul; 42(1):52-64. PubMed ID: 1718685 [TBL] [Abstract][Full Text] [Related]
55. Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin. Haim N; Rosenblatt E; Wollner M; Ben-Shahar M; Epelbaum R; Robinson E Cancer Chemother Pharmacol; 1992; 30(3):243-4. PubMed ID: 1628376 [TBL] [Abstract][Full Text] [Related]
56. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Loehrer PJ; Lauer R; Roth BJ; Williams SD; Kalasinski LA; Einhorn LH Ann Intern Med; 1988 Oct; 109(7):540-6. PubMed ID: 2844110 [TBL] [Abstract][Full Text] [Related]
57. Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: the Memorial Sloan-Kettering Cancer Center experience. Motzer RJ; Bajorin DF; Vlamis V; Weisen S; Bosl GJ Semin Oncol; 1992 Dec; 19(6 Suppl 12):8-11. PubMed ID: 1336624 [TBL] [Abstract][Full Text] [Related]
58. The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Motzer RJ; Cooper K; Geller NL; Bajorin DF; Dmitrovsky E; Herr H; Morse M; Fair W; Sogani P; Russo P Cancer; 1990 Dec; 66(12):2476-81. PubMed ID: 2174300 [TBL] [Abstract][Full Text] [Related]
59. Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ-cell tumors. Long-term results. Pizzocaro G; Salvioni R; Piva L; Faustini M; Nicolai N; Gianni L Ann Oncol; 1992 Mar; 3(3):211-6. PubMed ID: 1316779 [TBL] [Abstract][Full Text] [Related]